33 related articles for article (PubMed ID: 8092633)
1. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
Sina S; Mohammad JM; Reza S; Anita M; Soudabeh E; Hadi M
Eur J Med Res; 2021 Jun; 26(1):65. PubMed ID: 34193287
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Financial Burden of Toxoplasmosis Encephalitis Treatment at a Safety Net Hospital.
Bogard SN; Lee JT; Patel M; Kempker RR
J Acquir Immune Defic Syndr; 2022 Nov; 91(3):276-279. PubMed ID: 36252242
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis.
Connolly MP; Goodwin E; Schey C; Zummo J
Pathog Glob Health; 2017 Feb; 111(1):31-44. PubMed ID: 28090819
[TBL] [Abstract][Full Text] [Related]
4. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
[TBL] [Abstract][Full Text] [Related]
5. [Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Ragnaud JM; Morlat P; Dupon M; Lacoste D; Pellegrin JL; Chene G
Presse Med; 1993 May; 22(19):903-8. PubMed ID: 8378280
[TBL] [Abstract][Full Text] [Related]
6. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
[TBL] [Abstract][Full Text] [Related]
7. Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
Arens J; Barnes K; Crowley N; Maartens G
S Afr Med J; 2007 Oct; 97(10):956-8. PubMed ID: 18000578
[TBL] [Abstract][Full Text] [Related]
8. [Recurrence of cerebral toxoplasmosis in 15 AIDS patients].
Walckenaer G; Leport C; Longuet P; Perronne C; Lacassin F; Vildé JL
Ann Med Interne (Paris); 1994; 145(3):181-4. PubMed ID: 8092633
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches for AIDS-related toxoplasmosis.
Behbahani R; Moshfeghi M; Baxter JD
Ann Pharmacother; 1995; 29(7-8):760-8. PubMed ID: 8520094
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin in the treatment of toxoplasmosis in AIDS.
Iannucci AA; Hart LL
Ann Pharmacother; 1992 May; 26(5):645-7. PubMed ID: 1591424
[No Abstract] [Full Text] [Related]
11. Movement disorders with cerebral toxoplasmosis and AIDS.
Nath A; Hobson DE; Russell A
Mov Disord; 1993; 8(1):107-12. PubMed ID: 8419793
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
